Search

Author/Creator Ritter, Timothy

2. AAPM Medical Physics Practice Guideline 5.a.: Commissioning and QA of Treatment Planning Dose Calculations — Megavoltage Photon and Electron Beams. (8th September 2015)

Authors:
Smilowitz, Jennifer B.; Das, Indra J.; Feygelman, Vladimir; Fraass, Benedick A.; Kry, Stephen F.; Marshall, Ingrid R.; Mihailidis, Dimitris N.; Ouhib, Zoubir; Ritter, Timothy; Snyder, Michael G.; Fairobent, Lynne
Journal:
Journal of applied clinical medical physics
Issue:
Volume 16:Number 5(2015)
Page Start:
14
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. AAPM MEDICAL PHYSICS PRACTICE GUIDELINE 5.b: Commissioning and QA of treatment planning dose calculations—Megavoltage photon and electron beams. Issue 9 (10th August 2022)

Authors:
Geurts, Mark W.; Jacqmin, Dustin J.; Jones, Lindsay E.; Kry, Stephen F.; Mihailidis, Dimitris N.; Ohrt, Jared D.; Ritter, Timothy; Smilowitz, Jennifer B.; Wingreen, Nicholai E.
Journal:
Journal of applied clinical medical physics
Issue:
Volume 23:Issue 9(2022)
Page Start:
n/a
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Automating linear accelerator quality assurance. Issue 10 (25th September 2015)

Authors:
Eckhause, Tobias; Al‐Hallaq, Hania; Ritter, Timothy; DeMarco, John; Farrey, Karl; Pawlicki, Todd; Kim, Gwe‐Ya; Popple, Richard; Sharma, Vijeshwar; Perez, Mario; Park, SungYong; Booth, Jeremy T.; Thorwarth, Ryan; Moran, Jean M.
Journal:
Medical physics
Issue:
Volume 42:Issue 10(2015)
Page Start:
6074
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Challenges in Using Real-world Clinical Practice Records for Validation of Clinical Trial Data in Inflammatory Bowel Disease: Lessons Learned. Issue 1 (19th December 2017)

Authors:
Afzali, Anita; Ciorba, Matthew A; Schwartz, David A; Sharaf, Mai; Fourment, Chris; Ritter, Timothy; Wolf, Douglas C; Shafran, Ira; Randall, Charles W; Kane, Sunanda V
Journal:
Inflammatory bowel diseases
Issue:
Volume 24:Issue 1(2018)
Page Start:
2
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Challenges in Using Real-world Clinical Practice Records for Validation of Clinical Trial Data in Inflammatory Bowel Disease: Lessons Learned. Issue 1 (1st January 2018)

Authors:
Afzali, Anita; Ciorba, Matthew A; Schwartz, David A; Sharaf, Mai; Fourment, Chris; Ritter, Timothy; Wolf, Douglas C; Shafran, Ira; Randall, Charles W; Kane, Sunanda V
Journal:
Inflammatory bowel diseases
Issue:
Volume 24:Issue 1(2018)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. Development and interinstitutional validation of an automatic vertebral‐body misalignment error detector for cone‐beam CT‐guided radiotherapy. Issue 10 (23rd August 2022)

Authors:
Luximon, Dishane C.; Ritter, Timothy; Fields, Emma; Neylon, John; Petragallo, Rachel; Abdulkadir, Yasin; Charters, John; Low, Daniel A.; Lamb, James M.
Journal:
Medical physics
Issue:
Volume 49:Issue 10(2022)
Page Start:
6410
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. Etrasimod as induction and maintenance therapy for ulcerative colitis (ELEVATE): two randomised, double-blind, placebo-controlled, phase 3 studies. Issue 10383 (8th April 2023)

Authors:
Sandborn, William J; Vermeire, Séverine; Peyrin-Biroulet, Laurent; Dubinsky, Marla C; Panes, Julian; Yarur, Andres; Ritter, Timothy; Baert, Filip; Schreiber, Stefan; Sloan, Sheldon; Cataldi, Fabio; Shan, Kevin; Rabbat, Christopher J; Chiorean, Michael; Wolf, Douglas C; Sands, Bruce E; D'Haens, Ge...
Journal:
Lancet
Issue:
Volume 401:Issue 10383(2023)
Page Start:
1159
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. Etrolizumab for maintenance therapy in patients with moderately to severely active ulcerative colitis (LAUREL): a randomised, placebo-controlled, double-blind, phase 3 study. (January 2022)

Authors:
Vermeire, Severine; Lakatos, Peter L; Ritter, Timothy; Hanauer, Stephen; Bressler, Brian; Khanna, Reena; Isaacs, Kim; Shah, Saumin; Kadva, Alysha; Tyrrell, Helen; Oh, Young S; Tole, Swati; Chai, Akiko; Pulley, Jennifer; Eden, Christopher; Zhang, Wenhui; Feagan, Brian G; Abraham, Philip; Acir Crip...
Journal:
Lancet gastroenterology and hepatology
Issue:
Volume 7:Number 1(2022)
Page Start:
28
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

10. Filgotinib as induction and maintenance therapy for ulcerative colitis (SELECTION): a phase 2b/3 double-blind, randomised, placebo-controlled trial. Issue 10292 (19th June 2021)

Authors:
Feagan, Brian G; Danese, Silvio; Loftus, Edward V; Vermeire, Séverine; Schreiber, Stefan; Ritter, Timothy; Fogel, Ronald; Mehta, Rajiv; Nijhawan, Sandeep; Kempiński, Radosław; Filip, Rafał; Hospodarskyy, Ihor; Seidler, Ursula; Seibold, Frank; Beales, Ian L P; Kim, Hyo Jong; McNally, John; Yun, Ch...
Journal:
Lancet
Issue:
Volume 397:Issue 10292(2021)
Page Start:
2372
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗